Pregabalin
Product Images NDC 69986-014

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 69986-014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sinotherapeutics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Equation (701a4c60 C022 4281 88d8 3984d5f56092 Equation 01)

An illustration showing the formula to calculate creatinine clearance (CLCr). The formula is: [(140 minus age in years) times weight in kilograms] divided by [72 times serum creatinine in mg/dL], multiplied by 0.85 for female patients.*

FDA Label Image

Figure (701a4c60 C022 4281 88d8 3984d5f56092 Figure 03)

A line graph comparing the percent of patients improved with Pregabalin versus placebo, plotted against percent improvement in pain from baseline. The graph shows two lines: a solid line for Pregabalin and a dashed line for placebo, with Pregabalin consistently demonstrating higher percentages of patient improvement across increasing pain improvement percentages.*

FDA Label Image

Label 165 mg (701a4c60 C022 4281 88d8 3984d5f56092 Label 165mg)

Label for Pregabalin Extended-Release Tablets 165 mg, manufactured for Sinotherapeutics Inc. The label indicates the product contains 30 tablets per container and provides storage instructions between 20°C to 25°C with permitted excursions. It includes dosage and use information advising to refer to prescribing information, and includes manufacturing details for both Sinotherapeutics Inc. and Haimen Pharma Inc.*

FDA Label Image

Label 330 mg (701a4c60 C022 4281 88d8 3984d5f56092 Label 330mg)

Label for Pregabalin Extended-Release Tablets 330 mg by Sinotherapeutics Inc. The label states the product name, extended-release form, strength of 330 mg, and quantity of 30 tablets. It includes storage instructions, dosage use advisory referencing prescribing information, and manufacturer details for Sinotherapeutics Inc. and Haimen Pharma Inc. Barcodes are present on both the left and right sides of the label.*

FDA Label Image

Label 82.5mg (701a4c60 C022 4281 88d8 3984d5f56092 Label 82.5mg)

Label for Pregabalin Extended-Release Tablets 82.5 mg by Sinotherapeutics Inc. The label indicates this is a prescription-only medication with 30 tablets per container. It includes storage instructions and manufacturing details, stating each tablet contains 82.5 mg of pregabalin. The label notes the product is manufactured by Haimen Pharma Inc. in China.*

FDA Label Image

Chemical Structure (701a4c60 C022 4281 88d8 3984d5f56092 Structure 02)

Chemical structure of pregabalin showing its molecular arrangement with amino and carboxyl functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.